Puttagunta Sailaja's Form 4 filing
Iterum Therapeutics plc (ITRM) · filed Dec 5, 2022
- Accession no.
- 0001209191-22-059733
- Filed
- Dec 5, 2022
- Trade date
- Dec 1-2, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.44K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Puttagunta SailajaCIK 0001792314 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Ordinary Shares | AGrant or awardAcquired | +8,334 | $0.00F2 | $0 | 8,334 | Direct | |
| Dec 2, 2022 | Ordinary Shares | SSaleDisposed | −3,365 | $1.32 | −$4,441.8 | 4,969 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2022 | Ordinary Shares | MOption exerciseDisposed | −8,334 | $0.00 | $0 | 24,999 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
Referenced by the price of 1 transaction in Table I.